Aldeyra Therapeutics Depreciation & Amortization 2011-2026 | ALDX

Annual Depreciation & Amortization Aldeyra Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
252 K	250 K	263 K	259 K	264 K	56.2 K	96.3 K	71 K	37.8 K	35.8 K	18.8 K	1.07 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
264 K	1.07 K	134 K

Quarterly Depreciation & Amortization Aldeyra Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	60.9 K	-	-	-	60.6 K	-	-	-	67 K	-	192 K	-	62.7 K	-	203 K	-	67.9 K	-	218 K	145 K	72 K	-	72.3 K	48.3 K	24.2 K	-	48.2 K	29.3 K	11.4 K	-	29.9 K	20 K	9.66 K	-	26.5 K	17.1 K	8.1 K	-	10.6 K	4 K	1.25 K	-	339	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
218 K	339	58.1 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	548 K	$ 4.14	0.36 %	$ 443 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.41	4.73 %	$ 230 M	Israel
Ardelyx ARDX	3.06 M	$ 6.06	1.94 %	$ 1.46 B	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.83	0.85 %	$ 3.03 B	USA
Aytu BioScience AYTU	5.38 M	$ 2.65	-1.12 %	$ 16.6 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
BioCardia BCDA	24 K	$ 1.2	-0.04 %	$ 8 M	USA
BioCryst Pharmaceuticals BCRX	1.25 M	$ 9.6	6.37 %	$ 1.98 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 9.48	-3.27 %	$ 613 M	USA
BioVie BIVI	229 K	$ 1.45	2.09 %	$ 2.14 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
BioMarin Pharmaceutical BMRN	79.6 M	$ 56.49	1.78 %	$ 10.8 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	1.25 K	$ 3.04	1.54 %	$ 259 M	USA
BioXcel Therapeutics BTAI	300 K	$ 1.16	-2.12 %	$ 14.2 M	USA
Cabaletta Bio CABA	1.65 M	$ 3.2	7.94 %	$ 322 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 3.21	4.56 %	$ 6.98 B	Israel
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Catalyst Biosciences CBIO	2.48 M	$ 19.97	2.94 %	$ 1.78 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Codexis CDXS	5.25 M	$ 1.97	7.97 %	$ 172 M	USA
Cerus Corporation CERS	1.43 M	$ 1.91	2.42 %	$ 364 M	USA
Cullinan Management CGEM	311 K	$ 15.4	6.72 %	$ 928 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.75	0.87 %	$ 205 M	USA